Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,000 | 150,000 | 127,000 | 206,000 | 148,000 |
| Marketable Securities | 759,000 | 828,000 | 632,000 | 803,000 | 351,000 |
| Receivables | 11,000 | 20,000 | 38,000 | 39,000 | 745,000 |
| TOTAL | $1,007,000 | $1,016,000 | $831,000 | $1,067,000 | $1,262,000 |
| Non-Current Assets | |||||
| PPE Net | 40,000 | 47,000 | 51,000 | 35,000 | 32,000 |
| Investments And Advances | 29,000 | 14,000 | 107,000 | 129,000 | 182,000 |
| Other Non-Current Assets | 63,000 | 73,000 | 106,000 | 114,000 | 116,000 |
| TOTAL | $132,000 | $134,000 | $264,000 | $278,000 | $330,000 |
| Total Assets | $1,139,000 | $1,150,000 | $1,095,000 | $1,345,000 | $1,592,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 42,000 | 18,000 | 17,000 | 20,000 | 10,000 |
| Other current liabilities | 154,000 | 123,000 | 76,000 | 76,000 | 54,000 |
| TOTAL | $231,000 | $226,000 | $184,000 | $193,000 | $166,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 99,000 | 48,000 | N/A | N/A | N/A |
| Deferred Revenues | 35,000 | 85,000 | 91,000 | 97,000 | 102,000 |
| Other Non-Current Liabilities | 135,000 | 157,000 | 142,000 | 140,000 | 122,000 |
| TOTAL | $277,000 | $439,000 | $449,000 | $495,000 | $584,000 |
| Total Liabilities | $508,000 | $665,000 | $633,000 | $688,000 | $750,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,350 | 105,841 | 90,865 | 73,011 | 71,062 |
| Common Shares | 2,116,000 | 1,617,000 | 1,311,000 | 1,206,000 | 1,118,000 |
| Retained earnings | -1,485,000 | -1,132,000 | -849,000 | -542,000 | -275,000 |
| Other shareholders' equity | 0 | 0 | 0 | -7,000 | -1,000 |
| TOTAL | $631,000 | $485,000 | $462,000 | $657,000 | $842,000 |
| Total Liabilities And Equity | $1,139,000 | $1,150,000 | $1,095,000 | $1,345,000 | $1,592,000 |